Pharma Journalist -

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Global standard platform for genomic data, Wuxi NextCode announced partnering with Rhythm to develop and commercialize therapies aimed to treat rare genetic disorders of obesity. Rhythm…
Read More...

Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

NovoNordisk pilots an education and disposal program for Californian patients to purge sharp products to safely use the company’s medicines that are otherwise delivered by a syringe or…
Read More...

ESN group committed to natural skin care initiatives announced the rollout of its Ceramedx® brand of natural ceramide therapy products as a substitute for dry and sensitive skin. Earth…
Read More...

Bell Biosystems declared the results of their latest preclinical safety study at the Biotech Showcase in San Francisco. The study managed to comply with USP <151> pyrogenicity…
Read More...

Miraca Life sciences declared that it intends to change its name to inform Diagnostics with effect from immediate Avista Capital partners had acquired the company in November. The new…
Read More...

TAI diagnostics that oversees the health of transplanted organs announced the final closing of $10 million Series A preferred equity financing that will aid ongoing research and…
Read More...

Attune Medical has acquired 510 (k) clearance from the US Food and Drug Administration for new EnsoETM that administers tube feeds medication while cooling or warming patients at the…
Read More...